Myocardial Infarction Alters Adaptation of the Tethered Mitral Valve.

[1]  R. Levine,et al.  Assessment of Mitral Valve Adaptation With Gated Cardiac Computed Tomography: Validation With Three-Dimensional Echocardiography and Mechanistic Insight to Functional Mitral Regurgitation , 2013, Circulation. Cardiovascular imaging.

[2]  E. Schwammenthal,et al.  Mitral valve enlargement in chronic aortic regurgitation as a compensatory mechanism to prevent functional mitral regurgitation in the dilated left ventricle. , 2013, Journal of the American College of Cardiology.

[3]  Ellen Kuhl,et al.  Evidence of adaptive mitral leaflet growth. , 2012, Journal of the mechanical behavior of biomedical materials.

[4]  Hiroyuki Okura,et al.  Influence of chronic tethering of the mitral valve on mitral leaflet size and coaptation in functional mitral regurgitation. , 2012, JACC. Cardiovascular imaging.

[5]  R. Bucala,et al.  Fibrocytes in health and disease. , 2010, Experimental hematology.

[6]  A. Leask.  Potential Therapeutic Targets for Cardiac Fibrosis: TGF&bgr;, Angiotensin, Endothelin, CCN2, and PDGF, Partners in Fibroblast Activation , 2010, Circulation research.

[7]  R. Strieter,et al.  Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis. , 2010, The international journal of biochemistry & cell biology.

[8]  R. Levine,et al.  Developmental basis of adult cardiovascular diseases , 2010, Annals of the New York Academy of Sciences.

[9]  David Julius,et al.  Cellular and Molecular Mechanisms of Pain , 2009, Cell.

[10]  Suzanne Sullivan,et al.  Mitral Leaflet Adaptation to Ventricular Remodeling: Prospective Changes in a Model of Ischemic Mitral Regurgitation , 2009, Circulation.

[11]  K. Yutzey,et al.  Heart Valve Development: Regulatory Networks in Development and Disease , 2009, Circulation research.

[12]  Suzanne Sullivan,et al.  Active Adaptation of the Tethered Mitral Valve: Insights Into a Compensatory Mechanism for Functional Mitral Regurgitation , 2009, Circulation.

[13]  T. Denney,et al.  Profibrotic Growth Factor Genes in Chronic Isolated Mitral Regurgitation in the Dog Microarray Identifies Extensive Downregulation of Noncollagen Extracellular Matrix and , 2009 .

[14]  A. Gotlieb,et al.  Transforming growth factor-beta regulates in vitro heart valve repair by activated valve interstitial cells. , 2008, The American journal of pathology.

[15]  K. J. Grande-Allen,et al.  The Effects of Mitral Regurgitation Alone Are Sufficient for Leaflet Remodeling , 2008, Circulation.

[16]  Robert A Levine,et al.  Mitral Leaflet Adaptation to Ventricular Remodeling: Occurrence and Adequacy in Patients With Functional Mitral Regurgitation , 2008, Circulation.

[17]  M. Burdick,et al.  Differentiation of Human Circulating Fibrocytes as Mediated by Transforming Growth Factor-β and Peroxisome Proliferator-activated Receptor γ* , 2007, Journal of Biological Chemistry.

[18]  Xueli Yuan,et al.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.

[19]  N. Frangogiannis,et al.  The role of TGF-β Signaling in Myocardial Infarction and Cardiac Remodeling , 2007 .

[20]  R. Gomer,et al.  Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice , 2006, Proceedings of the National Academy of Sciences.

[21]  F Verrecchia,et al.  [Cellular and molecular mechanisms of fibrosis]. , 2006, Annales de pathologie.

[22]  Magdi H. Yacoub,et al.  Collagen synthesis by mesenchymal stem cells and aortic valve interstitial cells in response to mechanical stretch. , 2006, Cardiovascular research.

[23]  R. Markwald,et al.  An In Vivo Analysis of Hematopoietic Stem Cell Potential: Hematopoietic Origin of Cardiac Valve Interstitial Cells , 2006, Circulation research.

[24]  F. Schoen,et al.  Human Semilunar Cardiac Valve Remodeling by Activated Cells From Fetus to Adult: Implications for Postnatal Adaptation, Pathology, and Tissue Engineering , 2006, Circulation.

[25]  P. McCarthy,et al.  Mitral valve stiffening in end-stage heart failure: evidence of an organic contribution to functional mitral regurgitation. , 2005, The Journal of thoracic and cardiovascular surgery.

[26]  Arjun Deb,et al.  Bone marrow-derived myofibroblasts are present in adult human heart valves. , 2005, The Journal of heart valve disease.

[27]  Y. Suematsu,et al.  Age-associated aortic stenosis in apolipoprotein E-deficient mice. , 2005, Journal of the American College of Cardiology.

[28]  B. Griffin,et al.  Apparently normal mitral valves in patients with heart failure demonstrate biochemical and structural derangements: an extracellular matrix and echocardiographic study. , 2005, Journal of the American College of Cardiology.

[29]  D. Judge,et al.  TGF-β–dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome , 2004 .

[30]  Gideon Cohen,et al.  Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. , 2004, The Journal of thoracic and cardiovascular surgery.

[31]  R. Levine,et al.  Mechanism of Recurrent Ischemic Mitral Regurgitation After Annuloplasty: Continued LV Remodeling as a Moving Target , 2004, Circulation.

[32]  Joyce Bischoff,et al.  Heart valve development: endothelial cell signaling and differentiation. , 2004, Circulation research.

[33]  S. Rosenkranz.  TGF-β1 and angiotensin networking in cardiac remodeling , 2004 .

[34]  L. Leinwand,et al.  Valvular Myofibroblast Activation by Transforming Growth Factor-&bgr;: Implications for Pathological Extracellular Matrix Remodeling in Heart Valve Disease , 2004, Circulation research.

[35]  N. Khaper,et al.  Inflammatory cytokines and postmyocardial infarction remodeling. , 2004, Circulation research.

[36]  Douglas L Mann,et al.  Stress-activated cytokines and the heart: from adaptation to maladaptation. , 2003, Annual review of physiology.

[37]  S. Bolling,et al.  Myocardial Proinflammatory Cytokine Expression and Left Ventricular Remodeling in Patients With Chronic Mitral Regurgitation , 2003, Circulation.

[38]  P. Libby,et al.  Activated Interstitial Myofibroblasts Express Catabolic Enzymes and Mediate Matrix Remodeling in Myxomatous Heart Valves , 2001, Circulation.

[39]  K. Bailey,et al.  Ischemic Mitral Regurgitation: Long-Term Outcome and Prognostic Implications With Quantitative Doppler Assessment , 2001, Circulation.

[40]  A. Matsumori,et al.  Roles and Relationship of Macrophages and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in the Ischemic and Reperfused Rat Heart , 2000, Laboratory Investigation.

[41]  A. Carpentier,et al.  Correlation between clinical and histologic patterns of degenerative mitral valve insufficiency: a histomorphometric study of 130 excised segments. , 1999, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[42]  K S Kunzelman,et al.  Altered collagen concentration in mitral valve leaflets: biochemical and finite element analysis. , 1998, The Annals of thoracic surgery.

[43]  J. Gorman,et al.  Infarct size and location determine development of mitral regurgitation in the sheep model. , 1998, The Journal of thoracic and cardiovascular surgery.

[44]  R A Levine,et al.  Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry. , 1997, Circulation.

[45]  Richard P. Cochran,et al.  Collagen Synthesis Is Upregulated in Mitral Valves Subjected to Altered Stress , 1996, ASAIO journal.

[46]  S. Goldstein,et al.  Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. , 1992, Journal of the American College of Cardiology.

[47]  L M Wakefield,et al.  Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Timothy J Gardner,et al.  Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. , 2014, The New England journal of medicine.

[49]  M. Burdick,et al.  Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma. , 2007, The Journal of biological chemistry.

[50]  N. Frangogiannis,et al.  The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. , 2007, Cardiovascular research.

[51]  Raymond B. Runyan,et al.  Cell biology of cardiac cushion development. , 2005, International review of cytology.

[52]  S. Rosenkranz.  TGF-beta1 and angiotensin networking in cardiac remodeling. , 2004, Cardiovascular research.

[53]  D. Judge,et al.  TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. , 2004, The Journal of clinical investigation.

[54]  M. Entman,et al.  The inflammatory response in myocardial infarction. , 2002, Cardiovascular research.